Investing
The stock of Cargo Therapeutics CRGX, -3.13%, a clinical-stage biotech specializing in cancer treatments, rose 2.2% in its trading debut on Friday. The deal...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
Investing
U.S. natural-gas supplies in storage marked their biggest weekly decline in nearly three years — but that wasn’t enough to rally prices for the...
Investing
Oil futures rose Thursday to settle at their highest prices since late November after government data showed larger-than-anticipated drops in U.S. crude inventories and...
Investing
Oil prices gave up early losses to finish higher on Friday — with production outages in the U.S., strong economic data and concerns about...
Investing
Quarterly results from the United States’ largest cannabis company, Curaleaf Holdings Inc., and from Canada’s Canopy Growth Corp. missed analyst estimates, while shares of...
Investing
Bitcoin could reach a cycle high of as much as $150,000 in 2025, driven by the so-called halving event and institutional inflow brought by...
Investing
A biopic based on the life of tech billionaire Elon Musk is in development at film studio A24, according to a new report from...
Investing
Oil futures climbed Thursday, shaking off data that pointed to weak Chinese consumer demand to finish higher after a two-day drop that left crude...
Investing
By Stephen Nakrosis Plug Power said unprecedented supply challenges to the North American hydrogen network have hurt financial performance this year, but that it...
Investing
Hedging equity exposure with bond investments did not work out as hoped last year. The S&P 500 fell by 19.4% and instead of moving...
Investing
By Stephen Nakrosis The Food and Drug Administration said it granted approval of Ixchiq, the first vaccine for chikungunya virus, to Valneva Austria. Valneva...
Investing
By Stephen Nakrosis Blank-check company Arago Acquisition withdrew its planned initial public offering in a filing with the Securities and Exchange Commission. In its...
Investing
By Stephen Nakrosis Biolingus (Cayman) on Thursday said it had downsized its planned initial public offering to 360,000 shares and boosted its expected share...
